Intelgenx Technologies Corp Investor Relations Material
Latest events
Q4 2023
Intelgenx Technologies Corp
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Intelgenx Technologies Corp
Access all reports
Intelgenx Technologies Corp. is a pharmaceutical company focused on drug delivery solutions through its proprietary oral thin film technologies. Its primary product offering includes innovative oral films that provide immediate or controlled drug release, easing administration and improving patient compliance. The company also engages in the development of transdermal patches. Its film delivery platforms are applied across various therapeutic areas, with applications in human and animal health. The company is headquartered in Saint-Laurent, Quebec, Canada, and its shares are listed on the TSX.
Latest articles
)
D. E. Shaw & Co: Inside the Quiet Giant of Quant Finance
A deep dive into D. E. Shaw's evolution from a $28M quant startup to a $65B hedge fund giant, built on research, computing, and quiet consistency.
2 Jul 2025
)
Pershing Square Capital Management: Conviction, Reinvention, and Contrarian Investing
Pershing Square Capital Management has grown into a top-tier hedge fund through reinvention, conviction, and focus on long-term value creation.
2 Jul 2025
)
Eli Lilly: The Pharma Giant Behind Mounjaro and Zepbound
Eli Lilly's journey from insulin pioneer to global pharma giant, leading innovation in diabetes, obesity, and the future of metabolic health.
30 Jun 2025
Ticker symbol
IGX
Country
🇨🇦 Canada